Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.
Competitive strengths:
- One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
- Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
- Extensive geographical presence and diversified customer base.
- Strong R&D, sales and marketing capabilities
- Consistent financial performance track record.
Ami Organics IPO Details
|
IPO Opening Date |
Sep 1, 2021 |
|
IPO Closing Date |
Sep 3, 2021 |
|
Issue Type |
Book Built Issue
IPO |
|
Face Value |
₹10 per equity
share |
|
IPO Price |
₹603 to ₹610 per
equity share |
|
Market Lot |
24 Shares |
|
Min Order
Quantity |
24 Shares |
|
Listing At |
BSE, NSE |
|
Issue Size |
[.] Eq Shares of
₹10 |
|
Fresh Issue |
[.] Eq Shares of
₹10 |
|
Offer for Sale |
6,059,600 Eq
Shares of ₹10 |
Ami Organics IPO Tentative Timetable
|
IPO Open Date |
Sep 1, 2021 |
|
IPO Close Date |
Sep 3, 2021 |
|
Basis of
Allotment Date |
Sep 8, 2021 |
|
Initiation of
Refunds |
Sep 9, 2021 |
|
Credit of Shares
to Demat Account |
Sep 13, 2021 |
|
IPO Listing Date |
Sep 14, 2021 |
subscribe for long term
No comments:
Post a Comment